BioAge Labs

BIOANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$388.288 M

$8.46 +4.57%

Close of 22 Sept 2026

Revenue

$8.99M

#3177 by revenue

Earnings

-$80.6M

Loss-making

Shares outstanding

45,896,909

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#221VogenxVOGX$394.7M
#222RezoluteRZLT$389.0M
#223BioAge LabsBIOA$388.3M
#224Prelude TherapeuticsPRLD$387.0M
#225Benitec BiopharmaBNTC$382.0M

What if BioAge Labs were worth as much as…

Open the what-if tool →

Gold $30.2T

$658,736.51

Per share 77,865× higher

Bitcoin $1.74T

$37,947.11

Per share 4,485× higher

Nvidia $5.52T

$120,177.31

Per share 14,205× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for BioAge Labs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.